SEC Company Response from Q (QCLS) — Mar 24, 2020

Q/C TECHNOLOGIES, INC. (QCLS) (CIK 0001321834)
Date: March 24, 2020 · CIK: 0001321834 · Accession: 0001493152-20-004584

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-234449

Date

November 1, 2019

Author

AKERS

Form

CORRESP

Company

Q/C TECHNOLOGIES, INC. (QCLS) (CIK 0001321834)

Letter

Akers Biosciences, Inc.

Grove Road

Thorofare, New Jersey 08086

March 24, 2020

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

Securities and Exchange Commission

Washington, D.C. 20549

Attention: Paul Fischer

Re: Akers Biosciences, Inc.

Registration Statement on Form S-3, originally filed on November 1, 2019

File No. 333-234449 (the “Registration Statement”)

Request for Acceleration

Ladies and Gentlemen:

We hereby request the withdrawal of our request for acceleration, dated March 23, 2020, of the effective date of the Registration Statement that was requested to become effective at 4:00 p.m., Eastern Time, on March 24, 2020, or as soon thereafter as practicable.

Very
truly yours,
AKERS
BIOSCIENCES, INC.

Show Raw Text

CORRESP
1
filename1.htm

Akers
Biosciences, Inc.

201
Grove Road

Thorofare,
New Jersey 08086

March
24, 2020

VIA
EDGAR

U.S.
Securities and Exchange Commission

Division
of Corporation Finance

Securities and Exchange Commission

Washington, D.C. 20549

Attention:
Paul Fischer

    Re:
    Akers
    Biosciences, Inc.

    Registration
    Statement on Form S-3, originally filed on November 1, 2019

    File
    No. 333-234449 (the “Registration Statement”)

    Request
    for Acceleration

Ladies
and Gentlemen:

We
hereby request the withdrawal of our request for acceleration, dated March 23, 2020, of the effective date of the Registration
Statement that was requested to become effective at 4:00 p.m., Eastern Time, on March 24, 2020, or as soon thereafter as practicable.

    Very
                                         truly yours,

        AKERS
        BIOSCIENCES, INC.

    By:

    /s/
    Christopher Schreiber

    Christopher
    Schreiber

    Executive Chairman of the Board of Directors and Director

cc:
Rick A. Werner, Esq., Haynes and Boone, LLP

SecProbe.io